Familial hypercholesterolemia (FH) is a genetic disease, the underlying cause of which is
represented by mutations capable of influencing the metabolism of low-density lipoproteins …

Substance misuse, obesity, mental health conditions, type 1 diabetes, cancers, and
cardiovascular and chronic respiratory diseases together account for 41% of disability …

Introduction: Dyslipidemia is an abnormal condition of blood lipid levels with a global
prevalence of 31.2% which can cause various complications including atherosclerosis that …

Background/aim: Obesity is a chronic metabolic disease involving dysregulation of fat
metabolism that affects 13% of the world's population. Obesity has been linked to …

The treatment of Type 1 Diabetes Mellitus (T1DM) has always been a challenge for health
professionals in relation to glycemic control. Increased body fat has been related to a …

Rosuvastatin (RSV) is a widely used cholesterol-lowering medication, but its limited
bioavailability due to its susceptibility to stomach pH and extensive first-pass metabolism …

According to recent literature, there is a limited amount of data about the correlation of
vitamin 25 (OH) D, potassium (K), oxidative stress parameters, and other biomarkers with …

Background: Childhood dyslipidemia is a common condition that can lead to atherosclerotic
cardiovascular disease in adulthood. It is usually multifactorial. Screening for cholesterol …

Objectives Establishing direct reference intervals (RIs) for paediatric patients is a very
challenging endeavour. Indirect RIs can address this problem, using existing clinical …

Background Obesity in children is a major worldwide concern that has several negative
health consequences in both the short and long term. The objective of this study was to …